Answers are grounded in this paper and cite their sources.
Immunophilins are a family of binding proteins that are highly conserved in nature and mediate the actions of immunosuppressant drugs. The FK-506-binding protein (FKBP) subclass of immunophilin bind FK-506 and rapamycin and are of particular interest due to their potent neurotrophic activity. Here, the patent literature covering the structures of novel non-immuno-suppressant derivatives of FK-506 and rapamycin, and their claims pertaining to their potential use for the treatment of neurological disorders, are reviewed.
No takes yet. Share an insight, caveat, or question.
Babine et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: